Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,018 total articles
A director at Omeros Corp sold a portion of the company's common stock in May 2026, coinciding with recent negative market reactions to the firm's first-quarter earnings report. The sale was conducted under a prearranged trading plan, while analysis suggests limited immediate upside potential for the stock.
Interim CFO and CAO Saqib Baig sold shares of Peloton Interactive, Inc. (PTON) on May 22, 2026, under a pre-arranged Rule 10b5-1 trading plan. The sale occurred against a backdrop of stock volatility and recent corporate developments, including mixed Q3 earnings reports, the appointment of Siddharth Thacker as CFO, and the company's inclusion in th…
The Chief Financial Officer of Remitly Global, Inc. recently executed multiple sales of company common stock through a prearranged Rule 10b5-1 trading plan. This activity occurred against a backdrop of positive market developments for Remitly, including strong first-quarter earnings that surpassed expectations and strategic service enhancements in …
Michael Doak, a director at TWFG, Inc., has made substantial reported purchases of the company’s Class A Common Stock. These transactions occurred over several days in late May 2026, totaling an investment value exceeding $882,585. The timing of these acquisitions is noteworthy given that TWFG stock has experienced a notable decline over the past s…
Ankur Sinha, Chief Product and Tech Officer at Remitly Global, Inc. (NASDAQ:RELY), executed stock sales totaling over $160,000 using a prearranged trading plan. This activity occurs against a backdrop of robust company performance, highlighted by strong first-quarter 2026 earnings that surpassed market expectations. The firm also announced the expa…
The Chief Technology Officer of AppLovin Corp (NASDAQ:APP), Vasily Shikin, executed a significant sale of company shares totaling approximately $34.3 million on May 22, 2026. These transactions, conducted under an established Rule 10b5-1 trading plan, occurred while the stock had appreciated substantially over the past year and following strong fin…
Senior Vice President Chin-Chi Teng executed a sale of shares in Cadence Design Systems, part of a larger transaction involving option exercises. This insider activity occurred as the stock traded near its 52-week high. Despite the reported selling, the company continues to draw positive attention from analysts following strong first and second-qua…
The recent stock activities of Anirudh Devgan, President and CEO of Cadence Design Systems Inc., involve both significant sales and acquisitions via a pre-arranged trading plan. These personal transactions occur against a backdrop of strong corporate developments for Cadence, including increased guidance following an acquisition and multiple price …
Vasily Shikin, the Chief Technology Officer at AppLovin Corp (NASDAQ:APP), sold a significant block of stock totaling over $7.7 million on May 22, 2026. This transaction was executed under a pre-established Rule 10b5-1 trading plan. Despite the sale, recent corporate performance has been robust, with AppLovin reporting strong first-quarter 2026 res…
Diodes Inc. (NASDAQ:DIOD) recently saw its Senior Vice President of Worldwide Products Group, Andy Tsong, execute a sale of company common stock. This transaction occurred against a backdrop of strong corporate performance, including outperforming quarterly earnings and significant revenue growth for Q1 2026. Furthermore, the company announced majo…
Wu Ping Tak, Vice President of U.S. Operations at GSI Technology Inc., recently sold a substantial block of common stock after exercising options. This transaction occurs against a backdrop of significant company developments, including preliminary revenue figures for the fiscal year ending March 31, 2026, and an inclusion in the Russell 2000 Index…
The Chief Technology Officer of Diodes Inc., Francis Tang, recently sold shares totaling $997,196. This insider transaction occurred as the company's stock has experienced substantial gains over the last six months. Despite the notable selling activity, Diodes reported robust first-quarter results, with earnings per share and revenue both exceeding…
Diodes Inc's Chief Executive Officer, Gary Yu, recently executed transactions involving the sale of company shares. These filings occurred around late May 2026. Separately, the company reported strong first-quarter financial performance for 2026, with earnings and revenue exceeding analyst expectations. Furthermore, Diodes announced a leadership tr…
Senior Vice President of Worldwide Sales and Marketing at DIODES INC reported selling company common stock totaling $545,280 over two days in late May 2026. This activity occurred as the company posted strong Q1 financial results, including earnings per share that surpassed analyst forecasts. Furthermore, Diodes announced a leadership transition wi…
Blue & Silver Ventures, Ltd. recently executed several transactions involving GameSquare Holdings, Inc. (NASDAQ:GAME), acquiring a substantial amount of common stock through open market purchases over two days in May 2026. These purchases were complemented by the receipt of shares and warrants as part of a distribution from Goff Jones Strategic Par…
Acadia Pharmaceuticals’ Principal Accounting Officer, James Kihara, conducted a recent sale of company stock. This activity occurs against the backdrop of the firm's first quarter 2026 financial results, which missed analyst expectations on both earnings per share and revenue. Despite these headwinds, key financial metrics suggest certain areas of …
Bryan M Corsini, Chief Credit Officer at Banc of California (NASDAQ:BANC), sold a total of $285,731 worth of common stock shares on May 26, 2026. This transaction occurs against a backdrop of strong performance for the bank's stock, which has risen 39% over the past year. Furthermore, Banc of California recently reported financial results that surp…
Serge Saxonov, Chief Executive Officer of 10x Genomics, Inc. (NASDAQ:TXG), executed two separate sales last week, disposing of a total of 28,893 shares of Class A Common Stock valued at approximately $709,057. These transactions occurred while the stock trades near its annual high and following various analyst assessments.
Benjamin Hindson, President and Chief Scientific Officer of 10x Genomics, Inc., recently sold shares of the company's Class A Common Stock. This transaction occurred while the stock was trading near its yearly high, amidst broader positive developments including an 'Outperform' rating from William Blair and a price target increase from Stifel. Howe…
The recent activity of 10x Genomics, Inc. (NASDAQ:TXG), including a reported stock sale by its CFO and significant corporate partnerships, paints a complex picture for investors. While William Blair upgraded the rating to Outperform and Stifel raised price targets citing product adoption, concerns persist regarding institutional shifts and potentia…
Vice President, Corporate Controller, and Chief Accounting Officer at Itron, Inc. (NASDAQ:ITRI), David Marshall Wright, recently sold a block of company stock. This transaction occurred while the company reported robust first-quarter financial results, though some analyst sentiment remains cautious following an adjusted price target reduction.
A director of American Integrity Insurance Group, Inc. (NASDAQ:AII) executed a significant purchase of the company's common stock. This transaction occurs while the stock is trading close to its 52-week low. The buying activity takes place against a backdrop of recent mixed investor sentiment following the release of first-quarter 2026 earnings.
The market observed a transaction involving an executive at Itron, Inc. (NASDAQ:ITRI), specifically the sale of company stock by Senior Vice President Christopher E. Ware. This activity occurred alongside recent corporate financial disclosures, including Q1 2026 earnings results that exceeded expectations for both earnings per share and revenue. Ho…
The Chief Operating Officer of Kymera Therapeutics, Jeremy G. Chadwick, executed multiple stock sales in late May 2026, disposing of a total value of approximately $1.37 million. These insider transactions occurred while the company reported robust first-quarter financial results and presented positive data from its ongoing clinical and preclinical…
Senior Vice President Donald L. Reeves III sold company shares, a transaction occurring as Itron stock faces mixed signals from both financial performance reports and external analyst downgrades. While the company reported strong first-quarter earnings and revenue figures, investor sentiment was tempered by concerns over near-term growth trajectori…
